Titan Pharmaceuticals resubmits application for opioid treatment approval
Titan Pharmaceuticals Inc. on Monday announced the resubmission by Braeburn Pharmaceuticals of a New Drug Application to the U.S. Food and Drug Administration for Probuphine. Read More »